 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| RovathinS30774 | (2R,3R)-(-)-2,3-Butanediol | 24347-58-8 | 95% |
| RovathinS30775 | (2S,3S)-(+)-2,3-Butanediol | 19132-06-0 | 95% |
| RovathinS30776 | N-Benzyloxycarbonyl-4-piperidinesulfonyl chloride | 287953-54-2 | 95% |
| RovathinS30777 | 11-chloro-dibenzo[b,f][1,4]thiazepine | 13745-86-3 | 95% |
| RovathinS30778 | N-Phthaloyl-O-methyl-(S)-tyrosine | 52913-16-3 | 95% |
| RovathinS30779 | 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- | 274901-16-5 | 95% |
| RovathinS30780 | β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl- | 211914-51-1 | 95% |
| RovathinS30781 | Ethanol, 2-[2-(1-piperazinyl)ethoxy]-, dihydrochloride | 85293-16-9 | 95% |
| RovathinS30782 | 3-Thietanamine, 2,2,4,4-tetramethyl- | 80875-05-4 | 95% |
| RovathinS30783 | L-Tyrosine, 3-iodo-, methyl ester | 70277-02-0 | 95% |
| RovathinS30784 | Benzoic acid, 4-(1,1-dimethylethyl)-2-methoxy- | 52328-48-0 | 95% |
| RovathinS30785 | 2-[1-(1-Benzyl-piperidin-4-yl)-meth-(E)-ylidene]-5,6-dimethoxy-indan-1-one | 120014-07-5 | 95% |
| RovathinS30786 | 4-[2-(5-Ethyl-2-pyridyl)ethoxy]nitrobenzene | 85583-54-6 | 95% |
| RovathinS30787 | Methyl 2-bromo-3-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]propionate | 105355-25-7 | 95% |
| RovathinS30788 | 4(5H)-Thiazolone, 2-amino-5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- | 329249-53-8 | 95% |
| RovathinS30789 | 2-Pyridinamine, N-methyl-N-[2-(4-nitrophenoxy)ethyl]- | 329249-47-0 | 95% |
| RovathinS30790 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, hydrochloride | 302543-62-0 | 95% |
| RovathinS30791 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- | 122320-73-4 | 95% |
| RovathinS30792 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) | 155141-29-0 | 95% |
| RovathinS30793 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- | 122320-73-4 | 96% |
| RovathinS30794 | 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, sodium salt (1:1) | 105390-47-4 | 95% |
| RovathinS30795 | 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- | 111025-46-8 | 95% |
| RovathinS30796 | 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester | 88150-42-9 | 95% |
| RovathinS30797 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-ethenyl-8-oxo-, (6R,7R)- | 79349-82-9 | 95% |
| RovathinS30798 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R,3S)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-3-hydroxy-1-oxobutyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl | 76610-84-9 | 95% |
| RovathinS30799 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, diphenylmethyl ester, (6R,7S)- | 56610-72-1 | 95% |
| RovathinS30800 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-8-oxo-, (6R,7R)- | 36923-17-8 | 95% |
| RovathinS30801 | Topiramate | 97240-79-4 | 95% |
| RovathinS30802 | 4-Methoxyphenacyl chloride | 2196-99-8 | 95% |
| RovathinS30803 | Isonicotinic acid hydrazide | 54-85-3 | 95% |
|
|
|
|
